Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Clinical Rheumatology|December 21, 2019
Psychological distress and quality of life are improved in autoimmune patients through Tandem-Psychotherapy, combining individual hypnosis and eye movement desensitization and reprocessing (EMDR) treatment for trauma, followed by supportive-expressive group therapyMaria Teresa Corsetti, Edoardo Rossi, Sofia Bonvino, et al.
Electromagnetic Biology and Medicine|December 22, 2007
Extremely low frequency electromagnetic fields prevent chemotherapy induced myelotoxicityEdoardo Rossi, Maria Teresa Corsetti, Samir Sukkar, et al.
Acta Haematologica|November 5, 2005
The significance of minimal residual disease in stem cell grafts and the role of purging: is it better to purge in vivo or in vitro?Lorella Melillo, Nicola Cascavilla, Enrica Lerma, et al.
Leukemia Research Reports|November 28, 2014
Successful HLA haploidentical myeloablative stem cell transplantation for aggressive hepatosplenic alpha/beta (αβ) T-cell lymphomaGioacchino Catania, Francesco Zallio, Federico Monaco, et al.
Radiology Case Reports|September 10, 2021
Spontaneous splenic rupture during induction therapy in acute myeloid leukemia: An unusual caseRita Tavarozzi, Tiziana Borra, Gioacchino Catania, et al.
Leukemia & Lymphoma|June 21, 2013
Allogeneic stem cell transplant for adults with myelodysplastic syndromes: relevance of pre-transplant disease statusAlessandro Busca, Clara Pecoraro, Luisa Giaccone, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 18, 2024
The Italian Multicentric Randomized OPTkIMA Trial on Fixed vs Progressive Intermittent TKI Therapy in CML Elderly Patients: 3-Years of Molecular Response and Quality of Life Monitoring After Completing the Treatment PlanMichele Malagola, Alessandra Iurlo, Cristina Bucelli, et al.
Cancer Medicine|February 17, 2021
Molecular response and quality of life in chronic myeloid leukemia patients treated with intermittent TKIs: First interim analysis of OPTkIMA studyMichele Malagola, Alessandra Iurlo, Elisabetta Abruzzese, et al.
Hematological Oncology|May 9, 2025
Real-World Efficacy Profile of Compassionate Use of Asciminib in an Italian, Multi-Resistant Chronic-Phase Chronic Myeloid Leukemia (CML-CP) Patient PopulationMassimo Breccia, Antonella Russo Rossi, Valentina Giai, et al.
Pageof 1